Impairment of lipid metabolism due to excess metabolite accumulation induced by pyridoxal-5-phosphate (P-5-P)-deficiency andlor stimulated immune system has been studied and interpreted. Decreased amounts of phospholipids as well as deviations in phospholipid classes and fatty acid composition of phospholipids have been demonstrated due to kynurenine accumulation in the blood of P-5-P-deficient cardiovascular patients and white rats as well as in cardiovascular patients with activated immune system identified by an increased neopterin concentration in the blood (dilated cardiomyopathy) . The addition of P-5-P to the incubation medium for phospholipid biosynthesis in vitro did not change fatty acid incorporation into phospholipids, whereas it normalised fatty acid incorporation into phospholipids in liYer homogenates recei,·ed from P-5-P-deficient rats: 'Ine addition of kynurenine, neopterin and noradrenalin (accumulated m isolated heart tissue after addition of kynurenine and neopterin to incubation medium for isolated heart) to incubation medium for phospholipid biosynthesis in vitro induced an increase of saturated and a decrease of polyunsaturated fatty acid incorporation into phospholipids. These changes in fatty acid incorporation into phospholipids were followed by increased cholesterol concentrations in samples and an increased cholesterol/phospholipid ratio. Our results suggest that these changes in lipids are characteristic for decreased membrane fluidity, depressed cell cycle and lowered possibility of phospholipids to keep cholesterol in solution. P-5-P-deficiency is also accompanied with excess accumulation of homocysteine in the blood. The addition of L-homocysteine to the incubation medium for phospholipid biosynthesis in vitro was followed by inverse changes in fatty acid incorporation into phospholipids when compared with kynurenine , neopterin and noradrenalin. L-homocysteine induced a decrease of saturated and an increase of polyunsaturated fatty acid incorporation into phospholipids. The cholesterol concentration decreased in samples and the cholesterol/phospholipid ratio decreased, too . These findings suggest that changes in lipids induced by L-homocysteine are characteristic for increased membrane fluidity and stimulated cell cycle. In this study, we have observed a similar effect to L-homocysteine effect when L-homocysteine, L-tryptophan and 5,6,7,8-tetrahydrobiopterin were added to the incubation medium for phospholipid biosynthesis in vitro. The comparison of our results with data from the literature allows to suggest that excess metabolite accumulation due to activated formation and inactivated catabolism of it plays a significant role in quantitative and qualitative changes of lipids, especially phospholipids, and therefore participates in the regulation of membrane fluidity, cell cycle of normal and malignant cells as well as in keeping cholesterol in the state of solution.
Introduction
Atherosclerosis, ischemic heart disease and essential hypertension are associated with impaired lipid metabolism (1) . Although hypercholesterolemia, hypertriglycerolemia and decreased high density lipoprotein (HDL) cholesterol concentrations are the most frequently used indicators for atherosclerosis development and progression (2-7) in humans, other significant factors are indicated, too. At fIrst, quantita-108 V. Rudzite et a t : Tmpai.rment of lipid metabolism due to deficiency of pyridoxal-5-phosphatc and/or activated immune system: its interpretation ri ve and qualitative deviations in phospholipids have been mentioned as factors preventing or promoting to keep cholesterol in the state of solution (8, 9) . At second, low plasma concentrations of P-S-P have been indicated as a risk factor for coronary artery disease (10) . At third, a potential role of L-homocysteine in atherogenesis has been elucidated due to its promotion of vascular endothelial and smooth muscle cell growth (11 , 12) . This article is devoted to the pathogenetic significance of metabolic abnormalities due to P-5-Pdeficiency and/or stimulated immune system to contribute to quantitative and qualitative changes of lipid metabolism and its intetpretation. In this context, some observations in lipid metabolism as well as some experiments with P-S-P, kynurenine, neopterin, noradrenalin and S,6,7 ,8-tetrahydrobiopterin are repeated.
Materials and Methods
In 10 healthy individuals, 2S patients with ischemic heart disease (10 with angina pectoris and stenocardia, 9 with myocardial infarction, 6 with sinus node disease, 3 with chronic atrioventricular block), 23 patient with dilated cardiomyopathy and 48 patients with essential hypertens ion, we have examined P-5-P-deficiency applying an oral load with 30 mg L-tryptophanlkg of body weight followed by kynurenine determination (13) in serum on an empty stomach and 3h after loading (14) . In patients with dilated cardiomyopathy the concentration of neopterin in blood serum has been determined by radioimmunoassay (16 ) 
to indicate possible viral or bacterial infection (IS) .
In 10 intact (control) and 20 experimental white Wistar male rats P-S-P concentration in serum. liver. kidney and heart tissue has been examined by the method of Serfontain and others (1 O).-deficienc y of P-5-P in experimental rats has been induced by direct antagonist of P-S-P, i.e. 20 mg of isoniazidlkg of body weight per os once a day for 2 months . In addition, 30 intact white Wistar male rats have been used for preparing liver tissue homogenates necessary for investigating phospholipid biosynthesis in vitro (17) . The lipids from serum, liver, kidney and heart tissue as well as from liver tissue homogenates used for phospholipid biosynthesis in vitro were extracted according to the method of Folch and others (18) . Whole cholesterol concentrations were determined by the method of Engelhart and Smirnova (19) , HDL-cholesterol concentrations in serum by the method of Assman and others (20) . For determination of serum triglycerol concentrations, LACHEMA biotests have been applied. The method of Urbach and Raabe (21) was used for the determination of phospholipid concentrations . Thinlayer chromatography was applied for the quantificaPteridinesNol. II/No. 4 tion of phospholipid classes, and the method of Kates (22) was used to prepare the phospholipid samples for fatty acid content examination by gas chromatography. A conventional technique of gas chromatography for fatty acid methylesters was applied, where the carrier gas was helium and the sorbent was chromosorb covered with DEAG. The distribution of fatty acid methylesters was obtained at 2100C using the flame ionization detection and the adequate speed of helium. The correctness of the distribution was controlled with methylester standard substances (SERVA or SIGMA) in the time of analysis as well as in the time of each unclear case. We have also examined the incorporation of fatty acids into li ver tissue phospholipids of intact and P-5-P-deficient rats by the m ethod of N ilsson (17) using rat li\'er tissue homogenate in Krebs-Ringerphospate buffer (pH = 7.4) containing 0.3% albumin. The samples were incubated at 370C for 4 h . Then to every test tube 60~1 of 20% fatty acid solution in chlorefoffil (palmitic , stearic, oleic, linoleic, linolenic and arachidonic in equivalent amount; SIGMA) and 40~t! of glycerol were added. Subsequently all test tubes were incubated once m ore at 370C for 4 h. After the second incubation 75 m] of chloroform: methanol mixture (2: 1) was added to each sample The samples were mixed and allowed to stand for 40 min. at room temperature. Then the chloroform methanol extract was filtered and the filtrate \\as carefull y treated according to Folch and others (IS ) For the examination of cholesterol and phosp holipid concentrations as well as fatty acid composition of phospholipids the methods mentioned aboYe \\ere used . To investigate the sign ific ance of P-5-P, L-tryptophan, its m etab olites, pteridines. (neopterin and 5, 6,7,8-tetrahydrobiopterin) noradrenalin, L-homocysteine and L-homocystine on fatty acid incorporation into phospholipid as well as on cholesterol and phospholipid concentrations in samples, all examined substances were added to experimental test tubes before the first incubation.
The statistical significance between the values obtained from healthy individuals, intact rats or control test tubes and patients, experimental rats or experimental test tubes was calculated by Student's t-test (23) . P-values below 0.05 considered to indicate significant differences.
Results
In healthy individuals the mean kynurenine concentration ± S.D. was 12.4 ± 4.5~moVL three hours after 30 mg L-tryptophan loading/kg body weight. In 39 patients (10 with ischemic heart disease; 29 with arterial hypertension) the mean kynurenine concentration ± SD was 10.3 ± 2.1 J..I.mol/L after L-tryptophan loading Rudzite et al: Impainnent of lipid metabolism due to deficiency of pyridoxal-5-phosphate and/or activated immune 109 system: its interpretation not statistically significant). Therefore we conclude rnat this group of patients was without P-S-P-deficien-:y. In the remaining 60 patients (IS with ischemic neart disease, 23 with dilated cardiomyopathy and 19 \\ith essential hypertension) the mean kynurenine con-:entration ± SD was elevated after L-tryptophan loading: 22.0 ± 3.0 IlmollL (P < 0 .001) indicative for P-S-P -defi ciency.
On an empty stomach the mean neopterin concentration ± SO in blood serum was 18.6 ± 2.8 nmollL in patients with dilated cardiomyopathy, while in healthy llldividuais it was S.34 ± 0.14 nmollL (P < 0.001). No difference existed between neopterin concentrations at fast ing state and after L-tryptophan loading. Also the concentrations of kynurenine in these patients at fastlI1g state were elevated: S .34 ± 0 . 18 IlmollL in patients and 2.7S ± 0.17 Ilmo llL in healthy individuals (P < 0 .001).
...J Fi g . l shows the lipid profile of blood serum in healthy individuals and in 2 groups of patients with and without P-5-P-deficiency with cardiovascular pathology. In both groups of patients whole cholesterol concentrations in serum were increased, while HDLcholesterol concentrations were decreased if compared with healthy individuals. There was no difference in whole cholesterol and HDL-cholesterol concentrations between groups of patients with cardiovascular pathology. Concentrations of triglycerol and whole phospholipids differed between healthy persons and the two groups of cardiovascular patients. In patients with P-5-P-deficiency, an increase of triglycerol concentrations and a decrease of phospholipid concentrations were apparent when compared with healthy individuals and cardiovascular patients without P-5-P-deficiency.
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Further investigations were devoted to the analys is of phospholipids (Fig.2) . A decrease of phosphatidylcholine (lecithin) and an increase of phosphatidy lserine and phosphatidic acid content of phospholipids were found in cardiovascular patients with P-5-P-deficiency. The analysis of fatty acid composition of w hole phospholipid and lecithin ( Fig. 3 ) indicated an increased saturated (palmitic acid) and a decreased unsaturated (oleic and linoleic acid) fa tty acid content of whole phospholipid and lecithin in cardiovascular patients with P-5-P-deficiency. Similar changes in fatty acid content of phospholipids were found in erythrocyte membranes of cardiovascular patients with PSoP-deficiency. , in cardiovascular patients without P-5-P-deficiency (dotted bars) and in cardiovascular patients with P-5-P-deficiency (hatched bars); the difference is statistically significant (P < 0 .05).
FigA shows the concentration of P-5-P, whole cholesterol and phospholipid in serum, liver, kidney and heart tissue in intact (control) and experimental rats. One can see that the lowered P-5-P level induced by isoniazid is followed by a decrease of phospholipid concentrations in serum, liver and heart tissue and an increase of cholesterol concentration in heart tissue. The lowered P-5-P concentrations in serum and tissue are paralleled by elevated kynurenine concentrations in serum: 15.5f .lmollL in experimental rats and 9.9 f.lmoliL in control rats.
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.., ,;., FigA. Concentrations (mean ± SD) of P-5-P, phospholipids and cholesterol in serum, liver, kidney and heart tissue of intact rats (open bars) and experimental rats that 2 months peroral received 20 mg isoniazidlkg wet weight daily (hatched bars); the difference is statistically significant (P < 0.05).
When comparing the fatty acid composition of phospholipids in controls and rats treated with isoniazid, one observes an increase of saturated (palmitic and stearic) and a decrease of polyunsaturated (linoleic and arachidonic acid) fatty acid content in phospholipids of blood serum, liver, kidney and heart tissue in experimental rats with P-5-P-deficiency.
Further investigations have shown that the addition of P-5-P to liver tissue homogenates received from P-5-P-deficient rats (Fig.6 ) normalised the fatty acid incorporation into phospholipids, whereas the addition of P-5-P to the incubation medium for phospholipid biosynthesis in vitro that contained liver tissue homogenates received from intact rats (Fig .7) did not change the fatty acid incorporation into phospholipids as well as cholesterol and phospholipid concentration in samples. (C=18:2), linolenic (C=I8 :3) and arachidonic acid (C=20A) in phospholipids of samples contained intact rat liver homogenate (open bars) as well as experimental rat liver homogenate received from P-S-P-deficient rats (hached bars), or experimental rat liver homogenate with 4 nmol P-S-P/g wet weight added to sample (dotted bars). Samples were used to test for phospholipid biosynthesis in vitro. Incubation medium: Krebs-Ringer-phosphate buffer (pH=7.4) containing 0.3% albumin, fatty acid mixture and glycerol. Samples were incubated twice for 4 h at 37°C ; the difference is statistically significant P < O.OS).
...
.c Kynurenine, that accumulates in serum in P-S-Pdeficiency (14) as well as in conditions of a stimulated immune system in the organism (24, 2S) , increased the incorporation of saturated (palmitic acid) and V. Rudzite et al: Impairment of lipid metabolism due to deficiency of pyridoxal-5 -phosphate and/or activated immune system: its interpretation decreased the incorporation of p olyunsaturated (linoleic and arach idonic acid) fatty acid into phospolipids (Fig.8) . The concentrations of cholesterol as well as the cholesterol/phospholipid ratio increased, while the phospholipid concentrations decreased in samples . . Samples of rat liver tissue homogenate were used to test for phospholipid biosynthesis in vitro. Incubat ion medium: Krebs-Ringer-phosphate buffer (pH=7.4) containing 0.3% albumin, fatty acid mixture and glycero l. Samples were incubated twice for 4 h at 37°C; the difference is statistically significant (P < 0.00 I). PteridineslVol. lllNo. 4 N eop terin that together with kynurenine is increased in b lood serum and p lasma in diseases with stimulated immune system induces deviations of lipid metab o lism in samp les used for phospholipid biosynthesis in vitro similar to kynurenine (Fig.9) . There was also an increase of saturated (palmitic acid) and a decrease of polyunsaturated (oleic, linoleic and arachidonic acid) fatty acid incorporation into phospholipids . The ch o lesterol concentration as well as the cholesterol/phospholipid ratio increased, while the phosphlipid concentration was not altered in samples.
..... system: its interpretation for4 h at 37°C; the difference is statistically signicicant (P < 0.01).
It has been found (26) that the addition of kynurenine or neopterin to incubation medium for isolated heart is followed by an increase of noradrenalin concentration in isolated heart tissue. Addition of noradrenalin to incubation medium for phospholipid biosynthesis in vitro induced changes in lipid metabolism which were similar to the effects achieved by kynurenine and neopterin (Fig.1 0) : There was an increase of saturated (palmitic acid) and a decrease of polyunsaturated (linoleic and arachidonic acid) fatty acid incorporation into phospholipids. The cholesterol concentrations as well as the cholesterol/phospholipid ratio increased, while the phospholipid concentration decreased in samples containing noradrenalin. . Samples of rat liver tissue homogenate were used to test for phospholipid biosynthesis in vitro. Incubation medium; Krebs-Ringerphosphate buffer (pH=7.4) containing 0.3% albumin, fatty acid mixture and glycerol. Samples were incubated twice for 4 h at 37°C; the difference is statistical1y significant (P < 0.01) .
P-5-P-deficiency in the organism is also followed by an increase of homocysteine concentrations in the blood (27) . Addition of L-homocysteine to the incubation medium for phospholipid biosynthesis in vitro (Fig. 1 1 ) was followed by a decrease of saturated (stearic acid) and by an increase of polyunsaturated (arachidonic acid) fatty acid incorporation into phospholipids. The cholesterol concentrations as well as the cholesterol/phospholipid ratio decreased, while the phospholipid concentrations increased in samples. It is known that in hyperhomocysteinemia one part of Lhomocysteine can be oxidised to L-homocystine. The changes in lipid metabolism after addition of L-homocystine (Fig .12) to samples used for phospholipid biosynthesis in vitro were only moderate, but similar to the effects induced by L-homocysteine. Samples of rat liver tissue homogenate were used to test for phospholipid biosynthesis in vitro. Incubation medium: Krebs-Ringer-phosphate buffer (pH=7.4) containing 0.3% albumin, fatty acid mixture and glycerol. Samples were incubated twice for 4 h at 37°C ; the difference is statistically significant (P < 0.05).
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Also after adding L-tryptophan to the incubation medium for phospholipid biosynthesis in vitro (Fig.I3) , changes in lipid metabolism similar to Lhomocysteine were induced. L-Tryptophan induced a decrease of saturated (palmitic and stearic) and an increase of polyunsaturated (arachidonic acid) fatty acid incorporation into phospholipids . The concentrations of cholesterol as well as the cholesterol/phospholipid ratio decreased, while the concentrations of ph ospholipids remained unchanged in samples. Ringer-phosphate uffer (PH=7.4) contammg 0.3% albumin, fatty acid mixture and glyceroL Samples were incubated twice for 4 h at 37°C; the difference is statistically significant (P < O.OS -P < 0.001).
In repeated experiments with tetrahydrobiopterin, addition of the compound to the incubation medium for phospholipid biosynthesis in vitro induced changes in lipid metabolism similar to L-homocysteine and Ltryptophan (Fig.14) . 5,6,7,8-Tetrahydrobiopterin induced a decrease of saturated (stearic acid) and an increase of polyunsaturated (two types: of 8,11,14,7-arachidonic acid and of 5,8,11, 14-arachidonic acid) fatty acid incorporation into phospholipids. The cholesterol concentrations as well as the cholesterol/phospholipid ratio decreased, while the phospholipid concentration remained unchanged in samples containing teo'ah ydro biopterin. . Samples of rat liver tissue homogenate were used to test for phospholipid biosynthesis in vitro. Incubation medium: Krebs-Ringer-phosphate buffer (pH=7.4) containing 0.3% albumin, fatty acid mixture and glyceroL Samples were incubated twice for 4 h at 37°C; the difference is statistically significant (P < 0.001).
Discussion P-5-P, an active form of vitamin B6 (pyridoxine), was discovered from the year 1944 till 1952 (28) . Although P-S-P phosphate is necessary as a cofactor for many enzyme systems (28) , kynureninase (Lkynurenine hydrolase; EC 3.7.l.3) is one of the most sensitive enzymes influenced by P-S-P-deficiency. It cleaves kynurenine to anthranilic acid and 3-hydroxykynurenine to 3-hydroxyanthranilic acid. Moreover. the sensitivity of it to 3-hydroxykynurenine is 8-times greater than to kynurenine (29) . All aminotransferases, and so kynurenine aminotransferase (L-kynurenine: 2-oxoglutarate aminotransferase; EC 2.6.1.7) are P-5-P dependent enzymes, too. Kynurenine aminoo'ansferase cleaves kynurenine to kynurenic acid and 3-hydroxykynurenine to xanthurenic acid. Therefore, increased kynurenine, 3-hydroxykynurenine and xanthurenic acid accumulation after tryptophan loading can be used for identification of P-5-P-deficienc y (14) . Nevertheless methionine loading test followed by homocysteine or cystathionin determination in plasma or urine can be also used for identification of P-5-Pdeficiency (27) . Cystationine-a-synthetase (EC 4.2.1.22) which cleaves L-homocysteine to cystationine, is a P-5-P-dependent enzyme, too. Besides, a low level of P-5-P in blood and tissue is a direct indicator for P-5-P-deficiency (10) . For identification of P-5-Pdeficiency in this study, we have used L-0'Yptophan loading test followed by kynurenine determination in serum in our clinical observations and direct detennination ofP-5-P in our experimental investigations .
Although arteriosclerotic, dental and hepatic lesions have been found in pyridoxine-deficient monkeys (30) , the direct influence of vitamin B6 on cholesterol metabolism is not demonstrated till now. The results of this study also showed that increased cholesterol concentrations in cardiovascular patients did not depend on P-5-P-deficiency. On the contrary, the concentrations of phospholipids depended on P-S-P: in our cardiovascular patients with P-5-P-deficiency we observed a decreased concentration of phospholipids 1 16 V. Rudzite et al: Impairment of lipid metabolism due to deficiency of pyridoxal-5-phosphate and/or activated immune system: its interpretation in serum as well as a decreased content of lecithin phospholipids. The necessity ofP-5-P as a cofactor for phosphatidyl serine decarboxylation (31) explains an increase of the phosphatidyl serine content of phospholipids in our P-5-P-deficient cardiovascular patients. The analysis of fatty acid composition in serum and erythrocyte membrane phospholipids showed an increase of saturated and a decrease of unsaturated fatty acid content in our cardiovascular patients with P-5-P-deficiency. The results received in rats with experimentally induced P-5-P-deficiency were similar to those observed in P-5-P-deficient patients . Lowering of phospholipids, especially lecithin, in serum as well as deviations in fatty acid composition of phospholipids may, like other factors, promote cholesterol precipitation and atherosclerosis development and progression (8, 9) . It has been suggested, too, that phospholipid depletion plays a crucial role in increased membrane permeability to calcium inf1ux (32) , while phosphatidyl serine promotes calcium binding to sarcolernna (33) . The cholesteroVphospholipid ratio, the cholesterol concentration as well as fatty acid composition of phospholipids have been demonstrated to influence membrane fluidity. For example, neoplastic transformation of cells is known to be associated with a marked increase in cell surface fluidity. Both, cell cycle regulation and contact inhibition of cells, are shown to be linked with membrane fluidity (34, 35) . The increased cholesterol concenn'ations in membranes and decreased unsaturated fatty acid contents of membrane phospholipids have been observed in patients with essential hypertension, myocardial infarction as well as at ageing (36) (37) (38) (39) . Moreover, such diseases as essential hypertension (40), brady arrhythmias (41), cardiomyopathy (42, 43, 44) and atherosclerosis (45, 46) as well as aging are accompanied with elevated kynurenine and lor neopterin concentrations in the blood. So the results of this study on lipid metabolism, as well as on kynurenine and neopterin concentrations extend and agree well with the data of the literature. Kynurenine is a key metabolite of the tryptophannicotinic acid pathway. In mammals, more than 90% of total tryptophan is degraded in the liver through this pathway (48) . Tryptophan pyrrolase, i.e. tryptophan (2,3)-dioxygenase (L-tryptophan: oxygen 2,3-oxidoreductase; EC 1.13 .11.11), catalyses the tryptophan conversion to kynurenine in the liver (49) . This process is activated by the administration of tryptophan, corticosteroids (49, 50) , kynurenine (51, 52) and its metabolites (52) . In extrahepatic organs of mammals, kynurenine formation is catalysed by indole amine (2,3)-dioxygenase (IDO; indoleamine: oxygen 2,3-oxidoreductase; EC l.l3.11.17) (53), which is markedly PteridinesNol. IllNo. 4 induced by viruses, bacterial exotoxins and interferona (24, 54) . It is mentioned, that IDO takes part in the elevated kynurenine formation in pathological as well as in host defence mechanisms (54) .
Neopterin is produced from guanosine triphosphate in human monocyteslmacrophages stimulated by interferon-a (55). The key enzyme: cyclohydrolase I (EC 3.5.4.16) cleaves the purine of guanosine triphosphate and synthesyses 7,8-dihydroneopterin triphosphate. This key intermediate in pteridine biosynthesis is then converted by two subsequent enzymes (6-pyrovoyltetrahydropterin synthase and sepiapterin reductase) to 5,6,7,8-tetrahydrobiopterin, which acts as a cofac tor for several hydroxylases. Alternatively, 7,8-dihydroneopterin triphosphate is cleaved by phosphatases to 7,8-dihydroneopterin, which leaks from the cells and gives rise to neopterin concentration observed in culture supernatants and body fluids (25) .
Therefore in stimulated immune system both , kynurenine and neopterin concentrations are elevated, while in P-5-P-deficiency only kynurenine concentration is increased, especially after tryptophan loading, is increased. Both metabolites induce noradrenalin accumulation in isolated heart tissue after addition to incubation medium for isolated heart (26), while all three metabolites change lipid metabolism characteristic for a decreased membrane fluidity, depressed cell cycle, increased calcium accumulation in cells and calcium dependent cell dystrophy (34, 35) . Kynurenine, neopterin and noradrenalin induce calcium-dependent cell dystrophy (41 , 56, 57). Moreover, the deviations in phospholipids observed when kynurenine, neopterin or noradrenalin were added to the incubation medium for phospholipid biosynthesis in vitro, suggest that phospholipids can partly loose their possibility to keep cholesterol in the state of solution (8, 9) when these metabolites are present in excess . Our results of lipid metabolism in cardiovascular patients with P-5-P-deficiency as well as data of literature (36) (37) (38) (39) 58) further supports this conclusion.
Deficiency of P-5-P is also accompanied by increased homocysteine concentrations in the blood, especially after L-methionine loading (27) . Results of this study showed that L-homocysteine, added to the incubation medium for phospholipid biosynthesis in vitro, decreased saturated and increased polyunsaturated fatty acid incorporation into phospholipids. The cholesterol concentrations as well as the cholesteroVphospholipid ratio increased, while the concentrations of phospholipids decreased in samples containing L-homocysteine. Such deviations in lipids are characteristic for increased membrane f1uidity and stimulated cell cycle of normal and transformed cells (34, 35) . Our results received with L-homocysteine agree with data of the literature because excess homocysteine causes abnormal growth of endothelial and smooth muscle cells on the inner artery wall, buildingup plaques which may clog the lumen ofthe artery (11, (59) (60) (61) (62) .
An effect on lipid metabolism similar to L-homocysteine was observed after adding L-tryptophan to the assay system. It has also been demonstrated that tryptophan elevates blood leukocyte count in rats (63, 64) and can normalize leukocyte count in cases of leukopenia in healthy persons as well as in patients with hyperthyreosis and malignant tumors (65) . In vivo administration of tryptophan was able to stimulate nucleocytoplasmic efflux of hepatic RNA and protein synthesis. It was also shown that tryptophan administration in vivo and in vitro alone, but not single administration of other single essential amino acid, elicited a stimulatory hepatic response that was similar to that obtained with a complete amino acid mixture (66, 67) .
5, 6, 7, 8-Tetrahydrobiopterin was found to induce an effect similar to L-homocysteine and L-tryptophan on lipid metabolism in samples used for phospholipid biosynthesis in vitro. Although basal levels of tetrahydrobiopterin are very low in glioma cells, the rise of its concentration may promote tumour growth and survival (68) . Moreover tetrahydrobiopterin as well as its biosynthesis are necessary for growth of undifferentiated PC12 cells (68) .
The comparison of the results received in our studies with the data of literature indicates a crucial role of the metabolites in the regulation of the cell cycle as we ll as an influence on deviations of lipid profiles of blood and cell membranes. Cofactors by activation or inactivation of enzymes participate in normalization of increased or decreased amounts of metabolites which regulate cell membrane fluidity and cell cycle by rapidly induced quantitative and qualitative changes in lipids, especially in phospholipids. Our results of lipid deviations demonstrated in this study after addition of P-5-P to normal rat liver homogenate and to P-5-Pdeficient rat liver homogenate further support this conclusion. It is affirmed also by the normalization of homocysteine accumulation in the blood of patients with drug-induced homocysteinaemia after supplementary treatment with vitamin B6 and/or folic acid together with betaine (27, 69) while this treatment was ineffective in healthy individuals (27) .
